Structure |
Chemical Name |
CAS |
MF |
|
2-Pyridinecarboxamide, 4-hydroxy-N-methyl- (9CI) |
611226-36-9 |
C7H8N2O2 |
|
2-Pyridinemethanol, 4-hydroxy-3,5-dimethyl- (9CI) |
727375-13-5 |
C8H11NO2 |
|
Bumetanide Impurity 22 |
|
|
|
Rocuronium Bromide Impurity 32 、33 |
|
|
|
Flucloxacillin Sodium Impurity X |
|
|
|
Pitavastatin Impurity 98 |
|
|
|
Perospirone Impurity 29 |
|
|
|
Perospirone Impurity 24 |
|
|
|
Perospirone Impurity 7 |
1002359-81-0 |
|
|
2-methyl-4-(((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14- tetraen-1-yl)oxy)naphthalen-1-yl acetate |
|
|
|
Paxlovid Impurity 17 |
|
|
|
Related impurities of fluoxetine sodium 19 |
|
|
|
Fondaparinux sodium impurity 16 |
|
|
|
Fondaparinux Sodium Impurity 11 |
|
|
|
Oxacillin Impurity E |
|
|
|
AZOBENZENE-3-CARBOXYLICACID |
14474-22-7 |
C13H10N2O2 |
|
Bosutinib Impurity 40 |
|
|
|
Ticagrelor Impurity J&K |
|
|
|
Chloromethyl ethyl carbonate |
35179-98-7 |
C4H7ClO3 |
|
Bimatoprost Impurity 10 |
|
|
|
Carbetocin S-Oxide II |
|
|
|
Empagliflozin Impurity 82 |
2452301-16-3 |
C17H16ClIO2 |
|
Empagliflozin Impurity 88 |
|
|
|
Tofacitinib Impurity K |
2328165-36-0 |
C16H21N5O3 |
|
Olopatadine Impurity 13 |
55453-90-2 |
C18H16O4 |
|
Avibactam sodium Impurity CIA |
|
|
|
4-((2-amino-2-oxoethyl)amino)butanoic acid |
1096803-44-9 |
C6H12N2O3 |
|
Lenvatinib impurity LFZZ-17 |
|
C11H9NO4 |
|
Ornidazole Impurity 25 |
|
|
|
Pitavastatin Impurity 72 |
|
|
|
Febuxostat Impurity 109 |
|
|
|
Brivaracetam Impurity 37 |
|
|
|
Ticagrelor Impurity 133 |
|
|
|
4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-benzamide |
1187188-59-5 |
C14H12BNO4 |
|
2-Propenoic acid, 3-[4-(hydroxymethyl)phenyl]- |
219915-41-0 |
C10H10O3 |
|
L-Alanine, 3-[(R)-(carboxymethyl)sulfinyl]- |
61475-35-2 |
C5H9NO5S |
|
Phenol, 2-(2-phenyldiazenyl)- |
2362-57-4 |
C12H10N2O |
|
Olodaterol Impurity 24 |
|
|
|
Miglitol Isomer ImpurityB |
|
|
|
benzhydryl (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
|
43,50-Dicarboxy-cyanoco balamin |
|
|
|
(1R,4S) Sertraline Hydrochloride |
79896-32-5 |
C17H18Cl3N |
|
4-Desmethoxy-4-chloro Omeprazole Sulfide |
220757-74-4 |
C16H16ClN3OS |
|
N-Desmethyl Tamoxifen Hydrochloride |
15917-65-4 |
C25H27NO.ClH |
|
(3S,5S)-Atorvastatin sodium salt |
501121-34-2 |
C33H35FN2O5 |
|
2(1H)-Pyrazinone, 3-phenyl- |
2882-18-0 |
C10H8N2O |
|
1H-Thieno[3,4-d]imidazole-4-valeric acid, hexahydro-2-oxo-, stereoisomer (8CI) |
21788-37-4 |
C10H16N2O3S |
|
pazufloxacin |
166665-94-7 |
C16H15FN2O4 |
|
MK 485 |
28875-92-5 |
C10H14N2O4 |
|
1,3-Dioxane-4-aceticacid,6-(cyanomethyl)-2,2-dimethyl-,(4R,6R)-(9CI) |
807312-27-2 |
C10H15NO4 |
|
bromobenzarone |
94729-09-6 |
C17H13BrO3 |
|
digoxigenin-bis(digitoxoside) |
5297-05-2 |
C35H54O11 |
|
17 alpha-cyanomethyl-19-nortestosterone |
67473-36-3 |
C20H27NO2 |
|
desmethylazelastine |
47491-38-3 |
C21H22ClN3O |
|
(-)-menthyl benzoate |
6284-35-1 |
C17H24O2 |
|
3-methyleneisobenzofuran-1(3H)-one |
3453-63-2 |
C9H6O2 |
|
Irbesartan impurity A |
|
C25H28N6O |
|
N-DesMethyl SuMatriptan |
88919-51-1 |
C13H19N3O2S |
|
2-epi-(-)-EMtricitabine |
145416-34-8 |
C8H10FN3O3S |
|
Parent nucleus of cefotiaM hydrochloride |
372092-19-8 |
C13H21N7O3S2 |
|
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
111664-35-8 |
C22H19NO4 |
|
N-METHYL-3-CHLORO-3-PHENYL PROPYLAMINE HCL |
128036-32-8 |
C10H15Cl2N |
|
2,4,5-TRIFLUORO-3-METHOXYBENZOIC ACID |
11281-65-5 |
C8H5F3O3 |
|
METHYL TRIPHENYLMETHYL ETHER |
596-31-6 |
C20H18O |
|
CLOPIDOGREL CARBOXYLIC ACID |
144457-28-3 |
C15H14ClNO2S |
|
RAC (CIS/TRANS) DONEPEZIL N-OXIDE |
120013-84-5 |
C24H29NO4 |
|
5-Carboxy-2'-deoxyuridine |
14599-46-3 |
C10H12N2O7 |
|
METOPROLOL IMPURITY D |
|
C15H25NO3 |
|
NITRENDIPINE IMPURITY A |
|
|
|
TAMSULOSIN IMPURITY D |
|
C20H28N2O5S |
|
Macitentan Hydroxy amine Impurity |
2211059-05-9 |
C12H12BrN3O2 |
|
1,3-diethyl-1,3-dimethylurea |
31468-19-6 |
C7H16N2O |
|
2,4(1H,3H)-Pyrimidinedione, 6-[(3R)-3-amino-1-piperidinyl]-3-methyl- |
2276323-24-9 |
C10H16N4O2 |
|
7H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, ethyl ester |
7029-96-1 |
C11H14N4O4 |
|
N-(2-Amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acrylamide |
|
|
|
Rifampin Impurity 6 |
|
|
|
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo- |
2410658-30-7 |
C15H14FNO5 |
|
Hexanoic acid, 3-(hydroxymethyl)- |
81381-87-5 |
C7H14O3 |
|
1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)- |
936226-36-7 |
C30H36N6O10S2 |
|
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-, (1S)- |
946525-39-9 |
C22H27ClO6 |
|
Topiroxostat Impurity 42 |
|
|
|
Crisaborole intermediate |
1187188-60-8 |
C14H13BO4 |
|
Regorafenib Impurity MHY |
|
|
|
2-Thiazolamine, 5-(4-cyclohexyl-1-piperazinyl)-4-(4,5-dichloro-2-thienyl)- |
570407-63-5 |
C17H22Cl2N4S2 |
|
INDEX NAME NOT YET ASSIGNED |
2417213-74-0 |
C42H42N4O12S |
|
Lumateperone Impurity 6 |
313368-82-0 |
C23H26FN3O |
|
1H-?Indole-?5,?6-?diol, 1-?[3-?(4-?hydroxyphenyl)?-?1-?methylpropyl]?- |
2514709-72-7 |
C18H19NO3 |
|
6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid) |
|
|
|
4-Pyrimidineethanol, 6-bromo-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1307315-04-3 |
C16H13BrF3N5O |
|
Cycloocta[b]pyridine, 2-(4-ethyl-1,4-dioxido-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- |
2247538-61-8 |
C23H30FN3O2 |
|
Vonoprazan Impurity B-3 |
|
|
|
3-Azetidineacetamide, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- |
2271228-51-2 |
C16H19N7O3S |
|
Budesonide Impurity 26 |
|
|
|
Peramivir Impurity 48 |
|
|
|
Tolvaptan dehydroxylated impurity |
|
|
|
3-Quinolinemethanol, 2-cyclopropyl-4-phenyl- |
2153433-73-7 |
C19H17NO |
|
Avatrombopag Impurity 37 |
|
|
|
Piperacillin ImpurityABCDEFGHI |
|
|
|
5,6-DIMETHOXY-2-PYRIDIN-4-YLMETHYL-INDAN-1-ONE |
4803-57-0 |
C17H17NO3 |
|
3-(Dimethylamino)-1-(2-thienyl)-1-propanol |
13636-02-7 |
C9H15NOS |